The Intra-Extra Dimensional set-shift (IED) task assesses the processes involved in categorising stimuli into sets (visual discrimination of shapes vs. lines), and responding flexibly (shifting attention) to changes in stimuli. The IED
Cambridge Cognition Holdings PLC (LON:COG), the specialist developer of computerised tests for detection and monitoring of neuropsychological disorders, today announced a trading update for the year ending 31 December 2017.
Join Dr. Kiri Granger, Director of Neuroscience, Cambridge Cognition and Dr. Steve Brannan, Chief Medical Officer, Karuna Pharmaceuticals Inc. for a live discussion on improving clinical trial success in schizophrenia. The
How can you tell if a decision was impulsive or risky? Using the Cambridge Gambling Task to unpick how different brain regions, different drugs and different dopamine levels impact on decision-making. The Cambridge Gambling
Cambridge Cognition Holdings PLC are delighted to announce that both CANTAB Mobile and CANTAB Insight medical devices, designed for the assessment of cognitive health in clinical practice, have been approved
Social cognitive deficits have traditionally been linked with autism spectrum conditions. However, a recent paper from Cambridge Cognition suggests that deficits in social cognition are exhibited across a range of
The digital neuroscience company Cambridge Cognition Holdings plc (LON:COG), which develops and markets software products to improve brain health, has today released positive results from a pilot study to evaluate cognition
The CNS Summit takes place on the 16th-19th November in Boca Raton, Florida. The summit is a platform for fostering collaboration and innovation between the key players in cognitive technology. Cambridge Cognition will be
The 10th Clinical Trials on Alzheimer’s Disease (CTAD) conference was held in Boston last week. The event attended by world leading experts in Alzheimer’s disease clinical research focused on the earliest stages
Cambridge Cognition’s Dr. Steven Powell discusses their interim results, the reasoning behind the change in sales mix, the Innovate UK grant and the outlook for 2017 and 2018 in this exclusive interview with DirectorsTalk
© 2025 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
